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The non-medical use of prescription pain relievers has increased remarkably, posing 
social and public health concerns particularly in developed countries such as the United 
States. The management of pain experienced by pregnant women poses a challenge to 
clinicians considering the effects of the regimen on unborn babies. Guided by the health 
belief model, which aims to predict health-related behavior in terms of certain health 
beliefs and explain change and behavior maintenance as well as to guide health behavior 
interventions, this cross-sectional study aimed to understand the associations between 
misusing pain relievers and social determinants of health such as education level and race 
in pregnant women done using secondary analysis of data from a countrywide survey, 
National Survey on Drug Use and Health of 2016. These variables were dichotomized 
before running the binary logistic regression. A final study sample of 732 pregnant 
women were included, and 11.5% misused prescription pain relievers. Over 85% were 
non-African-American with most aged between 18 and 44, and over 82% had a high 
school diploma and above. Hydrocodone was the most misused prescription pain reliever. 
The regression showed that African-American women have a lower probability of 
misusing prescription pain relievers (Exp.(B) 0.06). Targeted interventions will use this 
data to address this public health concern among pregnant women therefore aiming to 
achieve Healthy People 2030 resulting in positive social change. 
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Section 1: Foundation of the Study and Literature Review 
Foundation of the Study 
Misuse of Prescription Pain Relievers   
The magnitude of the burden of pain especially noncancer pain is poorly 
measured as stated by Bonnie et al. (2019). With the emerging attention of pain and its 
undertreatment, pain relievers have been prescribed to alleviate this, leading to an 
increase in the prescriptions (Maxwell, 2011). Marijuana is the leading illicit drug used in 
the United States, followed by the misuse of prescription pain relievers such as Vicodin, 
OxyContin, and methadone, as stated by Lipari and Hughes (2017). Lipari and Hughes  
also stated that despite the decline in the rate of opioid misuse, the number of deaths 
following overdoses and admissions due to substance use has increased. Bonnie et al. 
(2019) stated that the opioid epidemic lies at an intersection between two public health 
challenges: reducing the suffering from the burden of pain and containing the 
consequences of opioid use. 
The non-medical use of prescription pain relievers has increased remarkably, 
posing both social and public health concerns, particularly in developed countries such as 
the United States. Most people are unaware they have this problem hence may not seek 
treatment. An estimated 22 million Americans in 2005 struggled with drug or alcohol 
problems, and the consequences of this have affected the quality of life for millions of 
individuals, families, and communities across the world (Sung et al., 2005). According to 
Substance Abuse and Mental Health Services Administration ([SAMHSA], 2019), 
alcohol is the third leading cause of preventable deaths among Americans with 88,000 
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approximate deaths annually. The SAMHSA reported an estimated 2.1 million people 
aged 12 and above having an opioid use disorder. Injury or death from accidents, poor 
school performance, and poor judgment and decision making are some consequences of 
underage drinking and substance abuse (SAMHSA, 2019). Teen pregnancy, sexually 
transmitted diseases such as human immunodeficiency virus (HIV), child abuse, and 
domestic violence are among other consequences of these habits as listed by the Office of 
Disease Prevention and Health Promotion (n.d.).  
Maxwell (2011) associated this increasing trend to factors such as aggressive 
marketing strategies by pharmaceutical companies, an increase in the prescriptions for 
such drugs, availability of the pain relievers both legally and illegally, and inappropriate 
or incorrect prescriptions by untrained physicians. Centers for Disease Control and 
Prevention [CDC] (2014b) lists Vicodin (hydrocodone + acetaminophen), OxyContin 
(oxycodone), and methadone as prescription opioids that can be used for pain 
management. According to the CDC (2018), over 191 million opioid prescriptions were 
dispensed to Americans across the nation in 2017 with more than 11.5 million people 
reporting misusing them in the past 1 year in 2016. Although men are more likely to die 
from misusing pain relievers than women, the CDC (2013) reported that about 18 women 
die every day from prescription pain reliever overdose with 6,600 deaths in 2010. Apart 
from death, consequences affect unborn children when pregnant women misuse pain 
relievers. Neonatal abstinence syndrome (NAS) is on the rise due to the increasing use of 
pain relievers by pregnant women (Krans & Patrick, 2016). NAS is a withdrawal 
syndrome that affects infants exposed to pain relievers during pregnancy and symptoms 
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such as seizures, respiratory complications, feeding difficulties, and low birth weights are 
seen shortly after delivery (Krans & Patrick, 2016). According to Krans and Patrick 
(2016), most NAS admissions of infants are likely to be Caucasians. 
Population and Demographics  
The United States is one of the more developed countries in the world with an 
estimated population of over 320,000,000. China and India are the only countries with 
higher populations. According to the World Health Organization ([WHO] 2019), the 
population in 2016 was 322,180,000 with a life expectancy at birth of 76 years for men 
and 81 years for women. In 2019 the population was estimated to be 328,239,523 with 
22.4% being those under the age of 18. Those above 65 years of age were 16% of the 
total population and the total female population was 50.8% (“U.S. Census Bureau 
QuickFacts: United States,” [USCB QuickFacts], 2019).  
Although the United States is cosmopolitan, the Caucasian population forms the 
highest percentage compared to other races. According to USCB QuickFacts, (n.d.-a), 
76.5% of the population in 2019 was made up of Caucasians while African Americans 
were 13.4%. Out of the Caucasian population, the Hispanic or Latino were 18.3% and 
White alone, not Hispanic or Latino was 60.4%. Based on education, according to USCB 
QuickFacts, 87.7% of the population aged above 25 years and above had a high school 
diploma or higher in 2019 in the United States, which was slightly higher than what was 
reported in 2018. USCB QuickFacts reported that 87.3% of the population aged 25 years 
and above had a high school diploma or higher in 2018. The Demographic Statistical 
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Atlas of the United States - Statistical Atlas (2018) also reported that 48.5% of the 
population aged 25 years and older had a high school diploma. 
Statement of the Problem  
Pregnant women are considered as a vulnerable population in terms of taking a 
relatively higher share of the disease burden, especially during disasters and emergencies 
(WHO, 2012). Children, the elderly, and immunosuppressed people are also considered 
vulnerable (WHO, 2012). Joszt (2018) stated that health and healthcare issues for 
vulnerable populations may be worsened by social factors that lead to worse access to 
care, increasing their morbidity and mortality compared to the general population. They 
also experience greater risk factors due to their vulnerability (Joszt, 2018). 
Pain can be experienced by anyone, and pregnant women are no exception. 
Pregnancy, which is considered a normal part of life, comes with different experiences by 
the expecting mothers, and these can include pain requiring interventions. According to 
Coluzzi et al. (2014), pre-existing conditions such as low back pain, rheumatoid arthritis, 
and fibromyalgia can cause chronic pain. Postural and hormonal changes during 
pregnancy can also lead to pain and discomfort (Coluzzi et al., 2014; Jankiewicz et al., 
2015). Coluzzi et al. (2014) stated that pain management in pregnancy is a challenge.  
The management of pain experienced by pregnant women poses a challenge to 
clinicians especially considering the effects of the regimen on unborn babies. With many 
clinicians fearing to prescribe pain relievers to pregnant women, some pregnant women, 
therefore, may decide to self-medicate to relieve pain leading to misuse of the pain 
relievers. U. S. Department of Health and Human Services ([HHS], 2019) and Volk 
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(2019) stated that the misuse of prescription drugs is the fastest-growing problem in the 
United States.  
This introduces the issue of health literacy. As stated earlier, a high percentage of 
American residents aged above 25 years had a high school diploma or higher in 2019 
(USCB QuickFacts, 2019). Erik Schmidt (2018) reported in the US Census Bureau that 
this is high, since in 1940 only 24% of the population aged 25 years and above completed 
4 years of high school or more. Education and other factors affect health literacy which 
helps individuals obtain, process, and understand basic health information and make 
appropriate health decisions (Brooks, 2019; Healthy People.gov, 2020). With a high 
population having attained a high school diploma or more, the link between education 
and misusing prescription pain relievers is important to study. 
There is a need to develop guidelines on pain management by obstetricians as 
stated by Ray-Griffith et al.(2018). According to Ray-Griffith et al., many chronic pain 
programs exclude pregnant women as they have pregnancy as an exclusion criterion, and 
this means all pain issues are left solely to the obstetricians. Findings from this study will 
provide information especially on education and race as variables that can guide the 
development of guidelines targeted at the specific populations. 
Specific Purpose of the Study 
One important public health goal in the United States is to improve the health, 
safety, and well-being of mothers, infants, and children. In achieving this, the health of 
their families is also improved, as stated by HHS (2014). Factors such as age, poverty, 
and perinatal health care affect pregnancy and childbirth. Determinants that influence 
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maternal health also influence the health of the children, and HHS (2014) stated that 
racial and ethnic disparities exist in the mortality of infants. The development of infants 
and children is influenced by factors such as health, nutrition, and behaviors during 
pregnancy and early childhood (HHS, 2014). Objective 11 of the maternal-infant and 
child health (MICH 11) aims to increase abstinence from alcohol, cigarettes, and illicit 
drugs with 11.4 focusing on illicit drugs (HHS, 2014). Misusing pain relievers during this 
period is one such factor. 
Goal 3 of the sustainable development goals (SDGs) which aims to ensure healthy 
lives for all has Target 3.5 addressing the prevention and treatment of substance abuse. 
Strengthening the prevention of substance abuse and treating those who abuse substances 
including narcotics and alcohol can be addressed by discussing pain reliever misuse. 
Findings from this study may include statistically significant associations between factors 
such as education and race and misusing pain relievers can aid in substance abuse 
prevention strategies. Stigma is the main concern with people who misuse drugs, and 
Health Poverty Action ([HPA] 2015) stated that people who use drugs are denied health 
care due to their drug use. HPA (2015) further elaborated this, stating that pregnant 
women face strong social stigma and get denied perinatal care including that of opioid 
substitution therapy and this affects their health and that of their unborn babies. The 
expenditure by states on narcotic services is also affected by this stigma (HPA, 2015). 
The goal is to strengthen the prevention and treatment of substance abuse especially with 
people with substance use disorders who receive treatment services. This study 
investigated the misuse of pain relievers by pregnant women in the United States. 
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Research Questions and Hypotheses 
The following research questions guided this study: 
RQ1: Is there an association between race and pain reliever misuse among 
pregnant women in the USA? 
H01: There is not an association between race and pain reliever misuse among 
pregnant women in the USA. 
Ha1: There is an association between race and pain reliever misuse among 
pregnant women in the USA. 
RQ2: Is there an association between education level and pain reliever misuse 
among pregnant women in the USA? 
H02: There is not an association between education level and pain reliever misuse 
among pregnant women in the USA. 
Ha2: There is an association between education level and pain reliever misuse 
among pregnant women in the USA. 
Operational Definition of Terms 
Pain reliever – A drug that is used to relieve, reduce or eliminate pain is referred 
to as a pain reliever, and this could be opioid, narcotic, or non-opioid (Stempniak, 2016).  
Pain reliever misuse – Pain reliver misuse refers to consumption of pain relievers 
in a way other than as prescribed by the doctor or using the pain relievers from non-
medical sources. The use of these pain relievers for non-medical reasons or recreational 
reasons can also describe pain reliever misuse (LeClair et al., 2015; McCabe et al., 2013). 
Three specific ways of misusing a pain reliever are described in NSDUH: using it without 
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a prescription of your own; using it in greater amounts, more often, or longer than one 
was told to take it; and using it in any other way a doctor did not direct you to use it.  
Pregnant women – The term pregnant women comes from the word pregnancy, 
which according to NIH (2017) describes the period when the fetus develops in a 
woman’s uterus and lasts for about 40 weeks when measured from the last menstrual 
period to delivery and is divided into three trimesters. Women in this condition are 
considered pregnant women. NSDUH relied on self-report on pregnancy questions. This 
study focused on all the women who were pregnant during the NSDUH of 2016. 
Nature of the Study 
Understanding the association between misusing pain relievers and social 
determinants of health such as education level, social-economic status, and race in 
pregnant women was done using secondary analysis of data from a countrywide survey. 
This is a cross-sectional study where two research questions will guide the research 
identifying variables that will answer them hence have an analysis plan; check the 
strengths and weaknesses of the dataset including describing the study population, 
sampling scheme and strategy, time when data was collected, assessment tools, response 
levels, and quality control measures; generate operational definitions of the variables 
including the confounders; and run the analysis starting with frequency tables and cross-




Literature Search Strategy 
Extensive scholarly search for journals, articles, and books done through the 
Walden Library was the main strategy used to find the relevant information for this study. 
I primarily used the Health Sciences databases including CINAHL & MEDLINE 
Combined Search, CINAHL Plus with Full Text, MEDLINE with Full Text, ProQuest 
Health & Medical Collection, Elsevier Publishing Company, and PubMed. Media from 
Walden Library such as those in statistics were also used. Other databases searched 
included Google Scholar, CDC, WHO, and dissertations from former Walden Students 
from the same program of DrPH. 
Key Search Terms 
Key search terms used during literature review include prescription pain 
reliever/painkiller misuse and pregnancy, pain, opioid misuse, substance abuse, drug 
abuse, Health Belief Model, medication-assisted treatment/MAT, cross-sectional study, 
secondary analysis, dichotomization and variables, multiple logistic binary regression, 
and regression coefficient. Other terms used are pain management or pain relief or pain 
control or pain reduction. Determinants of health, race, and pregnancy, education and 
pregnancy, and SDGs are other key terms used. 
Theoretical Framework 
The Health Belief Model (HBM), which aims to predict health-related behavior in 
terms of certain health beliefs, guided this study. The HBM as described by Boston 
University School of Public Health ([BUSPH] 2019) was developed in the 1950s by 
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social scientists Irwin M. Rosenstock, Godfrey M. Hochbaum, S. Stephen Kegeles, and 
Hoard Loventhal at the U.S. Public Health Service in order to understand why people 
failed to adopt disease prevention strategies and screening tests for early detection of 
disease. The HBM is used to explain change and behavior maintenance as well as to 
guide health behavior interventions as explained by Glanz et al. (2008). This model 
focuses on an individual’s perceptions of the threats posed by a health problem, the 
benefits of avoiding those threats, and factors affecting or influencing the decisions to 
act. Key concepts of HBM include perceived susceptibility or an individual’s likelihood 
of getting the health problem, perceived severity or the seriousness of contracting the 
health problem, perceived benefits or the potential benefits gained from changing 
behavior, perceived barriers or potential negative aspects of the particular health action, 
cues to action or what triggers them to act and self-efficacy or confidence in oneself to 
perform the required action (Glanz et al., 2008; National Cancer Institute et al., 2005).  
Figure 1 
Diagrammatic Presentation of HBM 
 

























Cues to action 
11 
 
Constructs of HBM and Misuse of Painkillers 
Perceived susceptibility is further described as an individual’s perception of the 
risk of acquiring a disease or condition. It is the belief about the likelihood of getting the 
condition or disease (BUSPH, 2019; Glanz et al., 2008). Glanz et al. (2008) explained 
this, stating that “...a woman must believe there is a possibility of getting breast cancer 
before she will be interested in getting a mammogram.” (p. 47). As noted earlier, various 
factors affect our health, with the environment and individual factors being significant 
(Danawi, Bryant, & Hasbini, 2016). The key concepts of the HBM focus on the 
individual’s perception and how they behave. Misusing pain relievers can be triggered by 
how these individuals perceive the pain. 
Perceived susceptibility is also explained by Parker and Anthony (2019) in their 
study on underage use of alcohol and this being a predictor of misusing prescription pain 
relievers. According to Parker and Anthony, underage drinking of alcohol should be a 
factor considered by clinicians when prescribing pain relievers to people who start to 
misuse prescription pain relievers. Mental disorders are also predictors of misusing 
prescription pain relievers including opioids. Sanmartin et al. (2019) stated that major 
depressive episode (MDE) is a common medical condition among women of 
reproductive age, affecting about 10.4% compared to 5.5% of men. According to 
Sanmartin et al., the risk of misusing opioids or having opioid use disorder among 
women with MDE was almost double those without MDE. This further explains 
perceived susceptibility.  
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Perceived severity as explained by BUSPH (2019) is the individual’s feelings on 
the seriousness of contracting the disease or condition. It also includes the feelings on the 
seriousness of leaving it untreated after evaluating the clinical and medical consequences 
such as pain and disability. Social consequences including the effects on their work and 
relationships in the family and the community are also included (BUSPH, 2019; Glanz et 
al., 2008). A combination of the individual’s beliefs on the likelihood of acquiring the 
disease or condition and its seriousness as well as consequences if left untreated is the 
perceived threat (Glanz et al., 2008). 
The outcomes or benefits of performing certain actions to reduce the threats posed 
by the disease or condition are the perceived benefits. According to Glanz et al. (2008), a 
personal belief in the benefits of an action will influence their decision to take action to 
reduce the threats. Glanz et al. further stated that an individual may not accept a 
recommended action unless they perceive the action to be beneficial in reducing the 
threat.  
Impediments, obstacles, and anything that limits one to take the required actions 
form the perceived barriers. Despite over 100 million Americans suffering from chronic 
pain leading to disabilities, Ray-Griffith et al. (2018) stated that women are more 
impacted than their male counterparts, and the pain thresholds of healthy women 
increases throughout their pregnancies peaking just before delivery. Ray-Griffith et al. 
further added that with back pain being a common ailment during pregnancy, there is 
limited information or guidelines on how to manage this. The health care providers caring 
for obstetrical patients, therefore, have limited time or inadequate training to provide the 
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appropriate pain management to their clients (Ray-Griffith et al., 2018). This can be 
viewed as one factor that brings out the construct of perceived barriers. Willis (2018) 
stated that the construct of perceived barriers is the most significant of the HBM when 
predicting behavior.  
Education attainment also portrays perceived barriers since education is a strong 
predictor of adult health as stated by Liu and Hummer (2008). According to Liu and 
Hummer, educational disparities exist in terms of age, period, race/ethnicity, and gender, 
and a higher level of education is associated with better health. These disparities have 
been in existence since the early years and changed in the 1970s as stated by Madigan 
(2009). According to Madigan, the passage of Title IX of the Education Amendment Act 
of 1972 protected students from being discriminated against based on their genders. 
Teenagers on the other hand have a weak understanding of the use of pain relievers as 
stated by Silva et al. (2011), who described the understanding as weak. Pregnant women 
include teenagers, and this is a significant barrier to their correct use of pain relievers. 
The stimuli needed to trigger an individual to act form the cues to action (Boston 
University School of Public Health, 2019). According to BUSPH (2019) and Glanz et al. 
(2008), individuals may do a cost-benefit analysis of actions to be taken comparing the 
expected benefits of taking the action and the barriers. Hence, a combination of the 
perceived susceptibility and perceived benefits minus the perceived barriers leads to the 
path of action.  
Self-efficacy or the level of confidence an individual has in their ability in 
performing a recommended action is important in behavior change (Glanz et al., 2008). 
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An individual will perform the recommended action based on the level of confidence 
they have in themselves, and this begins from the initiation of the recommended action to 
its maintenance (Glanz et al., 2008). Educational attainment is a variable that influences 
an individual’s perceptions indirectly, hence influencing their level of confidence in 
performing actions. According to Glanz et al. (2008), education influences perceived 
susceptibility, perceived severity, perceived benefits, and perceived barriers.  
Misuse of Painkillers 
  Misuse of prescription pain relievers is increasing, posing both social and public 
health concerns particularly in developed countries such as the United States. According 
to LeClair et al. (2015), this can occur with or without a prescription. LeClair et al. 
further stated that this habit is initiated during young adulthood with around 10.1% of 
those aged between 18- and 25-years reporting having misused pain relievers in the last 
year. Most people are unaware they have this problem and hence may not seek treatment. 
An estimated 22 million Americans in 2005 struggled with drug or alcohol problems, and 
the consequences of this have affected the quality of life for millions of individuals, 
families, and communities across the world (Sung et al., 2005). McLellan, 2017 reported 
that serious substance misuse including alcohol and prescription pain relievers,  have 
significant financial consequences citing costs of over $420 billion annually and over 
$120 billion in healthcare.  
Experimentation, normalization, and its use in combination with other substances 
such as alcohol are some of the motivators for this behavior. According to LeClair et al. 
(2015), young people may want to try new things. The acceptance by society that this is 
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normal in managing school, leisure, and boredom also is a motivator for the behavior. 
Other substances such as alcohol may require one to take pain relievers to moderate their 
effects (LeClair et al., 2015; McCabe et al., 2013). McCabe et al. (2013) added that some 
misuse pain relievers to get high, relieve tension, relax, or help sleep, and because these 
are safer than street drugs. 
Chronic pain impacts millions of people and is a major cause of lasting disability 
in America (Ray-Griffith et al., 2018a). Women have a higher burden compared to men, 
and Ray-Griffith et al. ( 2018) further added that the pain threshold in pregnant women 
peaks just before delivery. As noted earlier, pain is common during pregnancy. Sinclair et 
al. (2014) reported that 60% of pregnant women typically experience low back pain with 
another 20% experiencing pelvic pain. Coluzzi et al. (2014) and Ray-Griffith et al. (2018) 
noted that the management of chronic pain in pregnancy is a challenge for healthcare 
providers and hence some pregnant women may misuse the prescribed pain relievers.  
Coluzzi et al. (2014) argued that there is a risk of undertreatment of pain in 
pregnant women due to fear of using certain drugs during pregnancy. According to 
Elander et al. (2014), people with chronic pain can easily misuse pain relievers. Elander 
et al. (2014) explained that the incorrect use of pain relievers is on the increase especially 
because these pain relievers are also available over the counter (OTC). This is in 
alignment with Maxwell (2011), who attributed the increasing trend of prescription 
opioid misuse to factors such as inappropriate prescriptions and the wide availability both 
legally and illegally.  
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The effects of the misuse of these substances can be grouped into those affecting 
the mother and those affecting the child. According to Day and Sanju (2005), mothers 
may have self-neglect in various aspects and may even engage in prostitution and 
burglary to get their supplies due to dependence. The effects on the child trickle down 
from maternal infections, poor nutrition, and neglect leading to low birth weight and high 
incidence of preterm birth (Day & Sanju, 2005). Day and Sanju explained that exposure 
during the first trimester affects the development of the fetus while exposure in the 
second and third trimesters affects their growth and functioning.  
Misuse of drugs begins during the early parts of life, and Chakravarthy et al. 
(2013) stated that adolescent abuse is correlated to using drugs during adulthood and this 
being problematic. Volk (2019) noted that the fastest-growing drug problem in the United 
States is the use of prescription drugs affecting the lives of many. Stimulants that have 
effects common with cocaine, pain relievers that have effects common with heroin, and 
depressants are the ones mostly misused (Volk, 2019). Volk  also stated that prescription 
drug misuse affects judgment leading to an increase in risky behaviors. These may, in 
turn, lead to pregnancy and the acquisition of sexually transmitted infections. 
Anxiety and depression are some factors that lead to the misuse of prescription 
pain relievers. Kozhimannil et al. (2017) in their retrospective study sampled pregnant 
women aged 12 to 44 from the NSDUH 2005-2014 and reported a rate of 5.1% of non-
medical use of pain relievers and anxiety and depression were strong risk factors. Sung et 
al. (2005) report that the African-American individuals, women, those of low 
socioeconomic status, and those who view the use of pain relievers as favorable are at a 
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higher risk of misusing prescription pain relievers among the youth. Using univariate and 
multivariate models, variables such as age, gender, education, family income, and race, 
among others, were analyzed and from their findings, Sung et al. recommend targeting 
prevention measures to the at-risk groups.  
A study by Okewole and Fadebi (2017) concluded that drug abuse affects the 
performance of students in their academics. The analysis revealed that peer pressure was 
a significant reason for getting involved in drug misuse. Okewole and Fadebi listed 
getting over problems, deriving pleasure, and curiosity as some reasons for indulging in 
drug misuse, which is in alignment with LeClair et al. (2015) and McCabe et al. (2013). 
Counseling combined with other approaches was the most favorable strategy to be used 
to reduce this menace (Okewole & Fadebi, 2017). According to Kozhimannil et al. 
(2017) and Krans and Patrick (2016), medications such as methadone when used on 
pregnant women are most effective when used in combination with counseling. 
Policies and Programs 
With the increasing use of pain relievers during pregnancy and the consequential 
increase in NAS for the exposed infants, initiatives to improve access to treatment of 
substance abuse by pregnant women are now in place (Krans & Patrick, 2016). Krans and 
Patrick (2016) further added that criminalizing pregnant women with addiction is being 
embraced by most states with substance abuse during pregnancy now classified as 
criminal child abuse in 18 states and this could lead to the termination of parental rights. 
This, however, may prevent mothers from seeking prenatal care, hence clinicians should 
routinely screen all pregnant women for drugs and alcohol following the Health 
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Insurance Portability and Accountability Act of 1996 (HIPPA) regulations (Krans & 
Patrick, 2016).  
Medication-assisted treatment (MAT) using methadone or buprenorphine is 
recommended among pregnant women, and the benefits include reduced risk-taking 
behavior decreasing the transmission of infectious diseases such as HIV and minimized 
opioid withdrawal. MAT is most effective when used together with counseling or 
behavioral therapy, hence health personnel should work together (Kozhimannil et al., 
2017; Krans & Patrick, 2016). For NAS, adherence to a single treatment regimen through 
the standardization of care as given by the American Academy of Pediatrics resulted in 
improved outcomes (Krans & Patrick, 2016). 
To control the prescription of pain relievers, legislative initiatives addressing four 
main pillars, namely, educating everyone including the public, tracking, and monitoring 
of prescribers, proper disposal of medication, and the enforcement targeting pill mills and 
doctor shopping, lead to better protection of mothers and infants (Krans & Patrick, 2016).  
Social Change 
The prevalence of misuse of prescription pain relievers including opioids 
continues to rise and this poses a burden to the healthcare system. As earlier documented, 
MAT is most effective when combined with behavioral therapy through counseling and a 
standardized regimen works best for NAS (Krans & Patrick, 2016). Sehgal et al. (2012) 
stated that there is no single instrument that can be used to screen patients who can 
benefit from opioid therapy (MAT), and hence multiple tools and tests have to be used 
together. These include risk assessments as well as urine tests. Sehgal et al. suggested 
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that if there was one instrument for this task, iatrogenic addiction would be eliminated 
and this would lead to better outcomes. Spada et al. (2019) also recommended studies 
focusing on opioid agonist treatment in pregnant women to be carried out as this had 
better outcomes compared to outpatient substance use treatment alone. The findings from 
this study showed associations between race and the misuse of pain relievers among 
pregnant women and thereby will guide the targeting of treatment regimens. 
Victimization of those who seek help leads to shying away from health-seeking. 
As such, Krans and Patrick (2016) reported that following HIPAA regulations is 
essential. According to Sehgal et al. (2012), medical providers should be well-equipped 
with legal and regulatory issues surrounding the use of prescription pain relievers and 
pain relievers to manage chronic pain effectively while minimizing addiction at the same 
time.  
Understanding the association between misusing pain relievers and social 
determinants of health will guide in the interventions geared towards managing chronic 
pain among women of reproductive age hence addressing the public health concern. 
Krans and Patrick (2016) as cited by Kozhimannil et al. (2017) stated that for better 
prevention, screening, and treatment of nonmedical use of pain relievers, it is important 
to understand the factors that lead to this behavior. Romero et al. (2016) also reported 
that effective community interventions geared towards preventing teen pregnancies 
should consider the social needs of the groups at risk and data can help in identifying 
those with the greatest need.  
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The highest rate of teenage pregnancies among developed countries is in the 
United States, and young adults and teenagers make approximately 22% of the 
population. With this in mind, Jankiewicz et al. (2015) reported that teenagers are not 
well-represented in most studies and that pregnancy limits pain management options in 
women due to the potential adverse effects on both the mother and the unborn baby. This 
study focused on all pregnant women including teenagers. A focus on perinatal pain and 
its management using evidence from studies was also recommended by Jankiewicz et al. 
(2015) and Ray-Griffith et al. (2018), as the perinatal and postnatal periods are 
understudied. Understanding factors that are associated with misusing pain relievers early 
in life will, therefore, give the necessary scientific evidence in the management of pain in 
pregnancy, and hence findings from this study with pregnant women as the main subjects 
will play a significant role in this. As reported by Romero et al. (2016), addressing the 
social conditions using effective community-based interventions will reduce disparities 
especially when those with the greatest need are focused on.  
Even as the United States has a high rate of teen pregnancies compared to other 
developed countries, there exists a disparity in the distribution. According to Romero et 
al. (2016), racial, ethnic, and geographical disparities should be considered in the 
prevention strategies. To achieve health equity, unemployment, access to education, and 
higher family income can be addressed by community-level interventions (Romero et al., 
2016). The Robert Wood Johnson Foundation (RWJF), whose vision is to give everyone 
an equal opportunity to the healthiest life regardless of their different races, income, and 
living environments, requires collaboration by various sectors to deal with these 
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problems. Guided by 10 principles and the involvement of every individual in the society, 
a culture of health with healthy communities and lifestyles is built (Robert Wood Johnson 
Foundation, 2020). The collaboration will, therefore, achieve good health for the 
population (Plough, 2015). Creating a culture around health through health education and 
behavior change is a broad approach to achieving good health in the population, as stated 
by Mockenhaupt and Woodrum (2015). Addressing the issue of pain reliever misuse 
among pregnant women is a step towards achieving a culture of health in our society. 
CDC (2018) reported that the rate of teen pregnancies among Hispanic teens and 
non-Hispanic African-American teens was more than double that of the non-Hispanic 
Caucasian teens in 2017. American Indian/Alaska Native teens had the highest rate 
among all the races/ethnicities (CDC, 2018). This is in alignment with King Bowes et al. 
(2018), who stated that American Indian and Alaska Native (AI/AN) adolescents are at a 
higher risk for adverse sexual and reproductive health outcomes due to the lack of 
culturally appropriate sexual education reporting the early onset of sexual activity as well 
as higher numbers of sexual partners compared to the general population. According to 
Romero et al. (2016), Sedgh et al. (2015), and Sung et al. (2005), there is a higher rate of 
teen pregnancy among the Black race. Studying race as a predictor to whether pregnant 
women misuse prescription pain relievers will yield results that can be used to gear 
prevention strategies to this behavior and in the long run, address issues affecting most 
pregnant women including teenagers. 
About 50% of pregnancies in the United States have been reported to be 
unplanned (American Society of Addiction Medicine, [ASAM] 2017). This percentage 
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could be as high as 80% among women with substance use disorders ASAM, 2017). 
Policies on substance use, misuse, and use disorders during any stage of pregnancy and 
after delivery are important and hence screening women for their intention to get 
pregnant, prioritizing their treatment, educating them on issues regarding substance use 
and its effects on pregnancy, and regulatory and legal issues concerning these pregnant 
women are addressed in substance use programs (ASAM, 2017). This knowledge 
empowers them despite their substance use habits and depicts the construct of self-
efficacy and leads to positive social change. 
Summary 
In this section, a foundation of the study was presented including discussions on 
the gaps in knowledge and the problem statement. The purpose of this study was also 
discussed. An introduction of the research questions, the related null and alternative 
hypotheses, and the theoretical framework guiding the study were also discussed. The 
nature of the study and the literature search strategy together with the literature review 
described ways that other research has been done, and the review guided the study in 
terms of the implications on positive social change it will have. Programs and policies in 





Section 2: Research Design and Data Collection 
Introduction 
 Understanding the associations between misusing pain relievers and social 
determinants of health such as education level and race in pregnant women was done 
using secondary analysis of data from a countrywide survey. The National Survey on 
Drug Use and Health data set of 2016, labeled NSDUH-2016-DS0001. was used. A 
sample from the data was analyzed and findings reported and generalized to the 
population. This is a cross-sectional study where two research questions guided the 
research. El-Masri (2017) stated that researchers have the aim of concluding populations 
that have characteristics that interest them and since they may not be able to study the 
entire population due to time, cost, and logistical constraints, research participants with 
the characteristics are selected randomly or non-randomly from that target population. 
Findings from the selected sample, also known as the study sample, will then be 
generalizable to the entire population especially when it is representative of the 
population (El-Masri, 2017).  
Quantitative, qualitative, and mixed methods are the approaches of conducting 
research, and Regoniel (2015) stated that those research methods that use numbers to 
generalize phenomena are quantitative. Measurable information and data such as age, 
educational status, and socio-economic status among others are collected using 
standardized and pre-tested instruments. A normal population distribution curve can be 
drawn, hence proper sampling from the target population should be done for proper 
generalization of the findings. This study is quantitative as it has two research questions 
24 
 
and measurable variables such as education, the number of women of a certain race, and 
the number of women who are pregnant and their ages. 
Target Population 
Pregnant women of all ages from the NSDUH of 2016 formed the study 
population. NSDUH measures the illegal use of prescription and non-prescription drugs 
as well as mental disorders. The illegal use of common substances such as alcohol and 
tobacco are also measured (HHS, n.d.). According to HHS (n.d.), respondents to the 
survey’s face-to-face interviews are aged above 12 years, US civilians, and not 
institutionalized. This study focused on the misuse of pain relievers including Vicodin, 
OxyContin, Percocet, and others by pregnant women who were surveyed. Some other 
pain reliever (coded 37) was also included, and OTC pain relievers such as Tylenol, 
aspirin, Advil, and Aleve were excluded.  
Pregnant women have been excluded in most researches, and van der Graaf et 
al.(2019) stated that this reluctance is mainly due to the fear of harming the fetus. The 
reasons are valid, but van der Graaf et al. explained that there is a need for evidence-
based information from the pregnant women themselves. Pregnant women get sick or 
experience pain, and women who are sick or in pain get pregnant, so including them in 
research is important to achieve positive outcomes (van der Graaf et al., 2019). Targeting 
this group using data from a nation-wide survey gave findings that can be generalizable 
to the entire population of the United States. 
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Sampling Procedures and Sample Size Determination 
The NSDUH uses multistage area probability sampling methods to select their 
respondents for participation in the survey. According to SAMHSA(2017), stratification 
and first-, second-, and third-stage sample selections were done. A more detailed 
description of the design and sampling used in the NSDUH is available in the report 
(SAMHSA, 2017). Salas-Wright et al. (2015) in their study restricted their analysis to 
female respondents within the target age group. This study focused on all pregnant 
women and analysis was restricted to them. 
Inclusion and Exclusion Criteria 
Ethical considerations must be followed when dealing with human subjects, and 
the NSDUH used respondents aged above 12 years who were US civilians and were not 
institutionalized. According to SAMHSA (2017), all civilian residents of the 50 states 
and the District of Columbia who were not institutionalized and were aged above 12 were 
included in the national survey. Lofquist et al. (2012) reported that during the 2010 
census, 300.8 million people of the 308.7 million people were living in households in the 
United States. This was approximately 97%of the total population then. Hence 
respondents aged 12 and above who were non-institutionalized civilians would represent 
approximately 97% of the entire population. 
According to SAMHSA (2017), those with no fixed household address such as 
the homeless and/or transient persons not in shelters, the active military personnel, and 
those residing in institutions such as hospitals and jails were excluded in the survey. 
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Power Analysis for Sample Size Determination 
Identification of an appropriate sample size requires the level of statistical 
significance, alpha; the power desired to test the null hypothesis when it is false, beta; 
and the effect size which is the expected difference between the means (Creswell, 2014). 
Sawilowsky (2009) explained that Cohen in 1988 defined the effect size d = 0.2, 0.5, and 
0.8 as small, medium, and large. Larger and smaller values of d have been reported in 
different research studies, hence Sawilowsky revised the values of d as d (0.01) = very 
small, d (0.2) = small, d (0.5) = medium, d (0.8) = large, d (1.2) = very large, and d (2.0) 
= huge. 
Using G*Power 3.1.9.4 (Faul et al., 2009) to test whether the dichotomized 
independent variables were significant predictors of misusing prescription pain relievers, 
a minimum sample size of 333 was needed. Power analysis as explained by (Sawilowsky, 
2009) and testing of the model whether the independent variables, race, and education, 
predict the dependent variable, misuse of prescription pain relievers was done using a 
level of significance, α, set at 0.05. To achieve a power of 0.8 or 80 % and a medium 
effect size, a minimum sample of 333 was required to detect a significant model. There 
was an 80% chance of correctly rejecting the null hypothesis that race and education level 
were not associated with misuse of prescription pain relievers with 333 participants.  
Jenkins and Quintana-Ascencio (2020) explained that low sample sizes lead to 
challenges in reproducibility in research recommending a sample size N ≥ 8 for data with 
very low variance and N ≥ 25 for data with high variance. A minimum sample size of 333 
would detect a significant model and is greater than 8 and 25. 
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Datasets and Variables 
Based on my topic and research questions, the NSDUH-2016-DS0001 was used 
for the secondary analysis. The use of pain-relievers when not directed by doctor labeled 
PNRNMLIF was the dependent variable which was categorical in nature with 8 choices 
(1 = Yes, 2 = No, 5 = Yes LOGICALLY ASSIGNED (from skip pattern), 85 = BAD 
DATA logically assigned, 91 = NEVER USED/MISUSED PAIN RELIEVERS, 94 = 
DON’T KNOW, 97 = REFUSED, 98 = BLANK (NO ANSWER). Pregnancy status 
(PREGNANT labeled 1), race (NEWRACE2) which was categorical with 7 choices (1 = 
NonHisp White, 2 = NonHisp Black/Afr Am, 3 = NonHisp Native Am/AK Native, 4 = 
NnHisp Native HI/Other Pac Isl, 5 = NonHisp Asian, 6 = NonHisp more than one race 
and 7 = Hispanic), and education status (EDUHIGHCAT) which was categorical with 5 
choices (1 = Less high school, 2 = High school grad, 3 = Some coll/Assoc Dg, 4 = 
College graduate and 5 = 12 to 17 year olds) were the independent variables.  
Research Questions 
The following research questions guided this study in finding out if there were 
any associations between the variables: 
RQ1: Is there an association between race and pain reliever misuse among 
pregnant women in the USA? 
H01: There is not an association between race and pain reliever misuse among 
pregnant women in the USA. 
Ha1: There is an association between race and pain reliever misuse among 
pregnant women in the USA. 
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RQ2: Is there an association between education level and pain reliever misuse 
among pregnant women in the USA? 
H02: There is not an association between education level and pain reliever misuse 
among pregnant women in the USA. 
Ha2: There is an association between education level and pain reliever misuse 
among pregnant women in the USA. 
Analytical Strategies  
SPSS was used to import the data and run frequency tables and cross-tabulations 
and is presented in the form of bar graphs and pie charts for descriptive analysis. The 
dependent and independent variables were categorical. For pain-reliever misuse, 
PRNMLIF focus was on choices 1 (YES) and 0 (NO), and the rest were treated as 
missing data. As discussed earlier, American Indian and Alaska Native adolescents are at 
a higher risk for adverse sexual and reproductive health outcomes due to lack of 
culturally appropriate sexual education as stated by King Bowes et al. (2018), and 
Romero et al. (2016), Sedgh et al. (2015), and Sung et al. (2005) stated that there is a 
higher rate of teen pregnancy among the African-American population. Race 
(NEWRACE2), which had seven choices, was, therefore, dichotomized into African-
American (1) and non-African-American (0). For EDUHIGHCAT, the five choices were 
dichotomized into 0 = less high school and 1 = High school grad and above.  
Since my research questions were on associations between the binary dependent 
and independent variables, multiple logistic binary regression was used. Multiple logistic 
binary regression applies when there is a single dichotomous outcome and more than one 
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independent variable (McDonald, 2015). The aim is to find an equation that best predicts 
the probability of the value of the dependent variable as a function of the independent 
variables. It is a predictive analysis used to understand the functional relationship 
between the independent variables and the dichotomous dependent variable (McDonald, 
2015). This helped me identify the existence of any associations between the variables 
and confounders could also be accounted for (Laureate Education, 2016a; Laureate 
Education, 2016b). SPSS outputs were also used. 
According to Statistics Solutions (n.d.) using multiple logistic binary regression 
means that six assumptions must be met, and these are: 
1. The dependent variable should be binary - use of pain-relievers when not 
directed by doctor labeled PNRNMLIF focused on 1 = YES and 2 = NO choices 
hence binary in nature. 
2. Since it assumes that P(Y-1) is the probability of the event occurring, the 
dependent variable must be coded accordingly i.e. for a binary regression, the 
factor level 1 of the dependent variable should represent the desired outcome. 
For this study, PNRNMLIF 1 = YES. 
3. Model fitting with only meaningful variables being included – missing data was 
excluded. 
4. No multicollinearity – multiple linear regressions were run to determine this. 
5. The linearity of independent variables and log-odds 
6. Requires large sample – NSDUH is a national survey and this study focused on 
all women who are pregnant. 
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The goodness of fit was determined using Pearson’s chi-square statistic where 
large chi-square values indicate a poor fit for the model. A statistically significant result 
(p < 0.05) indicates that the data do not fit the model well. Hosmer Lemeshow test also 
determine if the observed values match the expected values in population subgroups. If 
the values are the same, you have a model that fits perfectly. These tests determine if 
findings from the study are representative of the population from which the sample was 
selected from. 
The regression coefficient (B) is the coefficient for the constant given in log odds. 
In logistic regression, the Exp(B) is the exponentiation of the B coefficient and is an odds 
ratio and is easier to interpret. According to Mathew Jones in Laureate Education, 
(2017d), an odds ratio of 1.00 means all things are equal and if B is negative then the 
Exp(B) will be less than one hence decreasing the odds and vice versa. Variables with 
significance levels p <.05 will be interpreted.  
Most researchers present results based on a 95% confidence interval as stated by 
Pourhoseingholi et al. (2013), and this study will also report results based on a 95% 
confidence interval. For more confidence in the results, a higher percentage can be used.  
Threats to Validity 
 The design and methods of research contribute to how sound the study is, and 
these, in turn, lead to the generalizability of findings to the population from which the 
study subjects were sampled. Internal validity is affected by factors within the study itself 
and the results deviate from the truth hence no conclusions can be drawn (Patino & 
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Ferreira, 2018). Without internal validity, external validity is irrelevant as stated by 
Patino and Ferreira (2018). 
Internal Validity 
The NSDUH is conducted yearly since 1971 and administered by SAMHSA and 
provides data on tobacco use, alcohol, illicit drugs (including non-medical use of 
prescription drugs such as pain relievers), and mental health issues in all the 50 states in 
the USA (National Institute on Drug Abuse [NIDA], 2018). According to NIDA (2018), 
RTI International, a non-profit research organization based in North Carolina, has 
conducted it since 1988.  
Drawing conclusions and making correct inferences is important, hence internal 
validity checked in this study include the history which ensures that all study participants 
experience the same external events; maturation which entails selecting study participants 
who may change or mature at about the same rate. For this particular study, the study 
population is all pregnant women, and comparisons, was done according to age groups 
(Creswell, 2014).  
Another component is regression/subject variability, which ensures that study 
participants with almost similar characteristics are selected (Creswell, 2014). Restricting 
the analysis to all the pregnant women surveyed fulfills the component of subject 
variability as described above and selection which involves the process of using random 
selection to get a fair distribution of study participants (Creswell, 2014). Mortality and 
instrumentation/task sensitivity are other components addressed by using a large sample 
size to account for dropouts and maintaining the same instrumentation during the 
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research (Creswell, 2014). NSDUH uses the same survey tool to collect data from all the 
study participants in the 50 states (SAMHSA, 2017). 
External Validity 
 The extent to which findings can be generalizable to other groups or contexts 
depends on their external validity. Incorrect inferences from study samples made to other 
people or settings and to different times lead to threats in external validity (Creswell, 
2014). The study subjects are described using the inclusion and exclusion criteria and this 
meets the external validity component of describing the population characteristics. In the 
NSDUH according to (SAMHSA, 2017) all civilian residents of the 50 states and the 
District of Columbia who were not institutionalized and were aged above 12 were 
included in the national survey and this study focused on all pregnant women. 
Generalizing findings to this population in the United States, therefore, is in alignment.  
The effect of time is another external validity factor and NSDUH is conducted 
yearly hence can find out if results can be replicated (Creswell, 2014). Data collection 
methodology for NSDUH, according to SAMHSA (2017), was stratification and first-, 
second-, and third-stage sample selections were done with a more detailed description of 
the design and sampling utilized made available in their report. 
External validity is increased by using broad inclusion criteria resulting in a study 
population that closely resembles the real-world population (Patino & Ferreira, 2018). 
Ethical Considerations 
Ethical considerations aim to protect the respondents and participants so that they 
are confident in giving their responses and in participating (Osho, 2017). Walden 
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University Ethics Committee/Institutional Review Board (IRB) reviewed the proposal 
and was approved on 9/14/2020 after meeting their ethical standards (Approval number 
09-14-20-0575030).  
For this study, a secondary analysis of the NSDUH-2016-DS0001 dataset was 
done. Directed by SAMHSA which is a Department of Health and Human Services 
agency, the NSDUH of 2016 applied ethical considerations especially in the recruitment 
of the study participants where those with no fixed household addresses, the active 
military personnel, and those residing in institutions such as jails were excluded 
(SAMHSA, 2017).  
Ethical considerations include principles of ethics such as respect for persons by 
acknowledging their autonomy and protecting their diminished autonomy (Yip, Han, & 
Sng, 2016). In this study, as seen in the NSDUH survey, voluntary involvement and 
exclusion of those who were institutionalized, those who were homeless, as well as those 
in active duty with the military was applied. Yip et al. (2016) also stated that beneficence 
and justice are important principles meaning doing no harm and being fair. According to 
SAMHSA (2017), NSDUH’s main aim is to measure the illegal use of prescription and 
non-prescription drugs as well as mental disorders and with multi-stage sampling, all 
regions are well-represented. 
Summary 
This section presents the research design and methodology used for the study. 
This is done by describing the NSDUH of 2016 giving characteristics of the population 
and how they were selected for the survey. The research population is also described and 
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a brief discussion on the sampling procedure done in the NSDUH of 2016, variables of 
interest, threats to validity, ethical considerations, and limitations of the study are also 
presented. The next section will present the results and findings in alignment with the 
research questions guiding it.  
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Section 3: Presentation of the Results and Findings 
Introduction 
This study was conducted to investigate the misuse of pain relievers by pregnant 
women in the USA. Using data from the NSDUH of 2016 and two research questions, 
this cross-sectional study was designed to understand the relationship between misusing 
pain relievers and variables such as education and race among pregnant women.  
To ensure only the target population was studied, the data were filtered by 
selecting only those respondents who responded Yes (1) to be pregnant. This is because 
this study was focusing on pregnant women. To achieve the best and most meaningful 
analysis, the data set and corresponding codebook of the NSDUH 2016 were adjusted to 
adequately reflect the variables of interest. The dependent variable, for example, was 
recoded to have two possible outcomes, Yes (1) and No (0), with Yes, logically assigned 
and Never used/misused pain relievers being assigned as Yes and No respectively.  
As earlier stated, the race of focus was the African-Americans, and the education 
level was whether one had a high school diploma or higher. These variables were 
dichotomized with 1 representing African-American while 0 represented all the other 
races, and for education 1 represented high school diploma and higher while 0 
represented below high school and those aged 12 to 17. 
According to the inclusion criteria for this study focusing on pregnant women, the 
final sample size was 732 pregnant women. With the adjustments, the following research 
questions and their respective null and alternative hypothesis guided the study: 
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RQ1: Is there an association between race and pain reliever misuse among 
pregnant women in the USA? 
H01: There is not an association between race and pain reliever misuse among 
pregnant women in the USA. 
Ha1: There is an association between race and pain reliever misuse among 
pregnant women in the USA. 
RQ2: Is there an association between education level and pain reliever misuse 
among pregnant women in the USA? 
H02: There is not an association between education level and pain reliever misuse 
among pregnant women in the USA. 
Ha2: There is an association between education level and pain reliever misuse 
among pregnant women in the USA. 
Descriptive Demographics of the Sample 
For the 732 pregnant women surveyed in 2016, 84 (11.5%) misused pain relievers 
and 648 (88.5%) did not misuse pain relievers as depicted in Table 1 below. 
Table 1 
Distribution of Pregnant Women According to Misuse Vs Non-Misuse of Prescription 
Pain Relievers (N=732) 
Prescription pain reliever 
misuse 
N % 
Yes 84 11.5 





Table 2 shows the distribution of pregnant women according to age. Most of the 
women were aged between 18 and 44 years (96.6%). Figure 1 is a pie chart showing the 
distribution of pregnant women according to age. 
Table 2 
Distribution of Pregnant Women According to Age (N=732) 
Pregnancy age N % 
1 – 15-17 years old 21 2.9 
2 – 18-25 years old 335 45.8 
3 – 26-44 years old 372 50.8 
4 – otherwise 4 0.5 
 
Figure 2 





Tables 3 and 4 show the distribution of the pregnant women according to race and 
the crosstabulation respectively. Most of the pregnant women were non-African-
American (85.1%). 
Table 3 
Distribution of Pregnant Women According to Race (N=732) 
Race N % 
African-American 109 14.9 
Non-African-American 623 85.1 
 
Table 4 
Race * Pain Reliever Misuse Crosstabulation 
  Pain reliever misuse  
  0 1 Total 
Race 0 540 83 623 
1 108 1 109 
Total  648 84 732 
 
Tables 5 and 6 show the distribution of the pregnant women according to 
education level and the crosstabulation respectively. Most of the pregnant women had a 
high school diploma and higher (84.2%). 
Table 5  
Distribution of Pregnant Women According to Education Level (N=732) 
Education N % 
High school and above 616 84.2 







Education * Pain Reliever Misuse Crosstabulation 
  Pain reliever misuse  
  0 1 Total 
Education 0 104 12 116 
1 544 72 616 
Total  648 84 732 
 
Study Results 
Table 7 below shows the prescription pain relievers misused in the past 12 months with 
hydrocodone being misused by eight pregnant women. 
Table 7 
Last Pain Reliever Used by Pregnant Women not Directed by the Doctor in the Past 
12 Months 
Last pain reliever used N % 
1 - Vicodin 4 12.1% 
2 - Lortab 1 3.0% 
5 - Hydrocodone 8 24.2% 
6 - OxyContin 3 9.1% 
7 - Percocet 2 6.1% 
10 - Oxycodone 1 3.0% 
12 - Ultram ER 1 3.0% 
14 - Tramadol 1 3.0% 
16 - Tylenol with codeine 3 
or 4 
4 12.1% 
17 - Codeine pills 1 3.0% 
26 - Suboxone 4 12.1% 
27 - Buprenorphine 2 6.1% 





Table 8 presents the chi-square tests with the statistics being the same (21.301) 
since no stepwise logistic regression was used and no blocking was done. The chi square 
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test is done to determine if there is any relationship between the variables. The p value, 
0.000 is the probability of obtaining the chi-square statistic, given that the null hypothesis 
is true. This is the probability of obtaining 21.301 if there is no effect that race and 
education level, taken together, have on the misuse of prescription pain relievers by the 
pregnant women. The p-value, 0.000 is less than 0.05 which is our critical value hence 
the model is statistically significant and not just by chance.  
Table 8  
Omnibus Tests of Model Coefficients 
  Chi-square df Sig. 
Step 1 Step 21.201 2 .000 
Block 21.301 2 .000 
Model 21.301 2 .000 
 
Table 9 presents Cox & Snell R-square and Nagelkerke R-square values (between 
0 and 1) to show the goodness of fit of the model of this study data. Approximately 3% 
and 6% of the variability in the misuse of prescription pain relievers is explained by both 
race and education level as demonstrated by the Cox & Snell R2 = .029 and the 
Nagelkerke R2=.056. Cox & Snell R-square summarizes the proportion of variance in the 
dependent variable associated with the predictor (independent) variables; however, its 
value range is between 0 and < 1. Nagelkerke R-square corrects this, adjusting the scale 













1 500.383a .029 .056 
a. Estimation terminated at iteration number 7 because parameter changed by less than 
.001. 
 
In Table 10, the Hosmer-Lemeshow test is non-significant since the value .940 is 
greater than .05 and this indicates a good model fit, while Table 11 is the contingency 
table for the Hosmer and Lemeshow Test with the observed and expected values being 
almost similar (71 observed vs 71.223 expected and 461 observed vs 460.777 expected as 
two examples) which also indicates a good model fit hence the sample is representative 
of the population (external validity). 
Table 10 
Hosmer-Lemeshow Test 
Step Chi-square df Sig. 
1 .006 1 .940 
 
Table 11 
Contingency Table for Hosmer-Lemeshow Test 
  Misused Did not misuse  
  Observed Expected Observed Expected  
Step 1 1 71 71.223 461 460.777 532 
 2 12 11.777 79 79.223 91 




On the classification, the specificity of the model was at 0% while the sensitivity 
of the model was at 100% with an overall classification percentage of 88.5. Table 12 
depicts this below. 
Table 12 
Specificity and Sensitivity of the Model 
   Predicted  
   Pain reliever misuse  
 Observed  Yes No Percentage 
correct 
Step 1 Pain reliever 
misuse 
Yes 0 84 .0 
No 0 648 100.0 
Overall 
percentage 
   88.5 
a. The cut value is .500 
 
For the binary logistic regression, Table 13 below shows that education level high 
school and above is not a significant predictor of misusing prescription pain relievers 
(b=-.039, se=.334, and sig=.907) since the significance level is .907 which is greater than 
.05. African-American race on the other hand is a negative and significant (b=-2.806, 
se=1.012 and sig=.006) predictor of the probability of misusing prescription pain 
relievers among pregnant women in the USA. 
Research question 1 stated as follows:  
RQ1: Is there an association between race and pain reliever misuse among 
pregnant women in the USA? 
H01: There is not an association between race and pain reliever misuse among 
pregnant women in the USA. 
 The null hypothesis was tested, using the Wald test for the strength of the 
significance between the predictive model and race. The African-American race is a 
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negative and significant (b=-2.806, se=1.012, Wald=7.691, and sig=.006) predictor of the 
probability of misusing prescription pain relievers. The OR indicates that for every 
pregnant woman of the non-African-American race, the odds of misusing prescription 
pain relievers decrease by 6% in the pregnant women of the African-American race. This 
means that the African-American race had a lower odds/probability of misusing 
prescription pain relievers. P-value 0.006 is less than 0.05 hence at 95% confidence level 
we fail to reject the null hypothesis and conclude that African-American race is a 
predictor of misusing prescription pain relievers among pregnant women in the USA.  
Research question 2 stated as follows:  
RQ2: Is there an association between education level and pain reliever misuse 
among pregnant women in the USA? 
H02: There is not an association between education level and pain reliever misuse 
among pregnant women in the USA. 
 The null hypothesis was tested, using the Wald test for the strength of the 
significance between the predictive model and education level. Education level is a non-
significant predictor of the probability of misusing prescription pain relievers (b=-.039, 
se=.334, Wald=0.014, and sig=.907). P-value 0.907 is greater than 0.05 hence at 95% 
confidence level we reject the null hypothesis and conclude that high school diploma and 
higher is not a predictor of misusing prescription pain relievers among pregnant women 






Binary Logistic Regression 
        95% C.I.for 
EXP(B) 
  B S.E. Wald Df Sig. Exp(B) Lower Upper 
Step 
1 
Education .039 .334 .014 1 .907 1.040 .540 2.001 
Race -2.806 1.012 7.691 1 .006 .060 .008 .439 
Constant -1.906 .310 37.872 1 .000 .149   
a. Variable(s) entered on step 1: EDUHIGHCAT2, NEWRACE3. 
 
All the six assumptions of using binary logistic regression were met as follows. 
The dependent variable should be binary - use of pain-relievers when not directed by 
doctor labeled PNRNMLIF was recoded as 1 and 2 with 1 representing those who 
misused prescription pain relievers and 2 representing those who did not misuse 
prescription pain relievers. 
Since it assumes that P(Y-1) is the probability of the event occurring, the 
dependent variable must be coded accordingly i.e., for a binary regression, the factor 
level 1 of the dependent variable should represent the desired outcome. After the recode, 
PNRNMLIF became PNRNMLIF2 and 1 represented yes/those who misused prescription 
pain relievers. 
Model fitting with only meaningful variables being included. The Hosmer-
Lemeshow test compares the observed and expected frequencies and assesses how well 
the model fits. The p-value was higher than the chosen p-value (.940 vs .05) hence the 
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predicted probabilities were not deviating from the observed probabilities indicating a 
good model fit.  
No multicollinearity – from the multiple linear regressions ran, we got variance 
inflation factors (VIFs) for pain reliever misuse as 1.007, for race as 1.000, and for 
education as 1.020 (see appendix A). These were all below 4. According to PennState 
Eberly College of Science (2018), VIFs exceeding 4 require further investigation and 
VIFs exceeding 10 require correction due to serious multicollinearity. 
The linearity of independent variables and log-odds. The dependent variable was 
categorical and so were the independent variables. In this study, all the variables were 
binary after the independent variables were transformed. 
Requires large sample – NSDUH is a national survey and this study focused on all 
women who were pregnant. After selecting the target group of pregnant women, a final 















Summary of Findings 
Variable N Percentage (%) 
Age 
  15 – 17 21 2.9 
  18 – 25 335 45.8 
  26 – 44 372 50.8 
  Otherwise 4 0.5 
Race 
  Non-African-American 623 85.1 
  African-American 109 14.9 
Education Level 
  Below high school 116 15.8 
  Above high school 616 84.2 
Prescription pain reliever misuse 
  Yes 84 11.5 
  No 648 88.5 
   
Total 732 100 
 
Summary 
People who misuse prescription pain relievers may have varying characteristics 
but based on the results from this study, race plays a significant role. Section 3 presented 
the results and findings of my study on the misuse of prescription pain relievers by 
pregnant women in the USA. Using data from the NSDUH of 2016, a secondary analysis 
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was done to find out the associations race and education level (independent variables) 
have with the misuse of prescription pain relievers (dependent variable) by pregnant 
women. Detailed analysis and discussion of these findings will be discussed in the next 
section, Chapter 4. Chapter 4 will elaborate on the findings and their interpretations, and 
the significance or positive social impact of these findings will also be discussed. These 
will be in alignment with the HBM model which guided this study. Recommendations 




Section 4: Application to Professional Practice and Implications for Social Change 
Introduction 
This study aimed to investigate the misuse of prescription pain relievers by 
pregnant women in the USA. Guided by two research questions, this cross-sectional 
study was undertaken to understand the associations between misusing pain relievers and 
social determinants of health especially education level and race in pregnant women 
using secondary analysis of data from a countrywide survey (NSDUH 2016). Section 4 
includes a summary and interpretation of the key findings, limitations of the study, 
recommendations especially for future studies, implications for professional practice and 
social change, and the conclusions. 
Interpretation of Findings 
In this section, findings are analyzed in alignment with the HBM model 
portraying the social impact they have.  
Table 15 
Summary of Results by Research Question and Predictor (Pain Reliever Misuse) 
Research question Results 
Is there an association between race and 
pain reliever misuse among pregnant 
women in the USA? 
African-American race decreases the odds 
of misusing prescription pain relievers 
(change by a factor of 0.06) 
Is there an association between education 
level and pain reliever misuse among 
pregnant women in the USA? 
Education level does not have an 
association with pain reliever misuse. 
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Pain Relievers Misused 
From this study, the most misused pain reliever was Hydrocodone followed by 
Vicodin which contains Hydrocodone, Tylenol with Codeine 3 or 4, and Suboxone. 
NIDA (2020) explains that Hydrocodone is the most prescribed prescription pain reliever 
in the USA, and this could be a factor leading to it being the most misused as shown by 
these findings. This can be viewed in terms of perceived barriers, but in this case, it is an 
enabler since it is commonly prescribed hence leading to higher availability and 
accessibility.  
Pregnancy and Misuse of Pain Relievers 
Pain is inevitable, and pregnant women experience it too. Management of pain in 
pregnant women is a challenge due to possible effects these may have on the fetuses 
(Black et al., 2019). Prescription of pain relievers including opioids for the management 
of such pain occurs, and some end up misusing them. According to Dirks (2018), there 
was a rise in the misuse of prescription pain relievers in the last 2 decades due to the 
increased awareness of chronic pain by physicians. Dirks noted that an even more 
distressing issue is that 99% of prescription hydrocodone produced is consumed by 
Americans. Black et al. (2019) stated that the treatment of pain should be at the lowest 
therapeutic dose and for the shortest duration possible, but with increased prescription 
and the trust people have in their doctors, the feeling of euphoria may lead to misuse of 
the drugs (Dirks, 2018). 
To achieve target 3.5 of the SDG 3 and RWJF vision of ensuring healthy lives and 
giving everyone an equal opportunity to good health regardless of their differences 
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including race, targeting prevention strategies to those who are at higher risk, which the 
findings from this study show to be the non-African-American race, will yield good 
results. Krans and Patrick (2016) state that controlling the prescription of pain relievers to 
protect mothers and infants should involve education and monitoring of prescribers. Non-
African-American individuals are at a higher risk of misusing prescription pain relievers 
among pregnant women. Targeting education messages to these women and their 
prescribers will lead to good progress toward achieving the SDG goals and the vision of 
the RWJF.  
Collier (2020) explained that among the prescription pain relievers used in 
pregnancy, opioids such as oxycodone and hydrocodone are prescribed for moderate to 
severe pain. Prolonged and increased amounts used lead to consequences such as NAS, 
premature deliveries, and poor fetal growth as well as the risk of stillbirths. These side 
effects can be traumatizing to the family members. According to Dirks (2018), these 
effects include those affecting the unborn fetus, and those that affect the people around 
the misusers. Neglect and child abuse, both physical and emotional, have been listed as 
some effects of misusing prescription pain relievers by pregnant women. 
Limitations of the Study 
Since this study was based on the NSDUH data which relied on self-reporting, the 
respondents may have failed to report that they were pregnant or may have been unaware 
of their pregnancy status at the time of the survey. Some may have reported that they 
were pregnant when they were not. However, the use of self-report measures of 
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pregnancy is considered to be a valid and reliable approach in epidemiological research, 
as stated by Overbeek et al. (2013). 
OTC pain relievers such as Tylenol, aspirin, Advil, and Aleve were excluded 
from the list of prescription pain relievers in NSDUH, as stated by SAMHSA (2017). 
According to Trottier et al. (2012), systemic non-opioid analgesics such as 
acetaminophen, aspirin, and nonsteroidal anti-inflammatory drugs are used to treat pain 
during pregnancy. CDC, (2019) lists Tylenol, aspirin, Advil, and Aleve as OTC 
medicines used by pregnant women. These could also be prescribed by medics for use to 
treat pain since not all medications are safe to use during pregnancy. 
Recommendations 
Pregnant women form a complex group to manage especially due to the unborn 
fetuses that they are carrying. Black et al. (2019) in their study explained that because of 
ethical concerns, safety information on drugs used during pregnancy is largely reliant on 
animal data. This is true for pain relievers. According to Ray-Griffith et al. (2018), pain 
management among pregnant women is left to the obstetricians. Pregnancy is also one 
exclusion criteria for most pain programs as explained by Ray-Griffith et al. (2018), yet 
they also experience pain. Studies and programs on pain management should include 
mothers who have recently given birth for evidence-based strategies to be developed.  
As noted by Black et al. (2019) and Ray-Griffith et al. (2018), pregnant women 
are excluded in various studies, hence recommending further studies to be conducted to 
understand the safety profile of these medications. Hydrocodone is highly misused; hence 
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more studies need to be conducted to establish a better understanding of its safety with 
race as a variable to focus on. 
Implications for Professional Practice and Social Change  
This study introduced African-American race as a factor that decreases the odds 
of misusing prescription pain relievers among pregnant women. Pregnant women 
surveyed during the NSDUH of 2016 formed the study population in this study hence the 
findings are generalizable to them. Black et al. (2019) Ray-Griffith et al. (2018) reported 
that pain management in pregnant women poses a challenge due to safety issues and this 
leads to obstetricians being left with the task of managing their pain on their own.  
Perceived susceptibility, which is one of the constructs of HBM, the model that 
guided this study, is reflected by the findings in terms of African-American race being a 
negative predictor of misusing prescription pain relievers among pregnant women. 
Strategies to combat the misuse of prescription pain relievers by pregnant women can be 
guided by this study’s findings since African-American race decreases the odds of 
misusing the prescribed pain relievers. The non-African-American race can be targeted 
by the strategies. Development of guidelines in pain management can be guided by this 
meaning the obstetricians should consider race when making their prescriptions and 
include in-depth education especially when it is inevitable to prescribe them. Ray-Griffith 
et al. (2018) listed guidelines that can be a starting point in the discussion of pain 
management among pregnant women including conducting thorough medical histories, 
discussing other substance use such as alcohol, and involving the pregnant women in 
establishing the treatment goals.  
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NIDA (2020) stated that these prescription pain opioids require attention due to 
the rising cases of NAS associated with the increasing prescriptions and deaths. The non-
medical use of prescription pain relievers can be addressed by involving prescribing 
clinicians as well as the patients. According to NIDA (2020), more than 84% of 
Americans had contact with healthcare professionals hence placing them in good 
positions to identify potential misusers. This could be through tracking refills and any 
frequent change in doctors. As these clinicians balance between those who will benefit 
from the prescriptions and those who are just misusers, they are also expected to educate 
them (NIDA, 2020).  
Clear education on how to take the prescriptions in terms of the correct dosage, 
potential drug interactions, and to never use other people’s prescriptions should be done. 
Proper disposal of leftover and expired prescription pain relievers and giving honest 
medical histories including what other prescriptions they may be taking is a role the 
patients can take in curbing this increase (NIDA, 2020). With the non-African-American 
race being at higher odds of misusing prescription pain relievers, clinicians should ensure 
that these patients get all the education and counseling regarding their correct use. 
Launched in August 2020, Healthy People 2030 (HP2030) maintained the 
objective of reducing the non-medical use of prescription pain relievers which was in 
Healthy People 2020 (HP2020). To achieve its mission of promoting, strengthening, and 
evaluating the nation’s efforts to improve its people’s health and well-being, one plan of 
action is to direct actions to specific groups HHS, n.d.). The department plans to use 
evidence-based data and findings from this study from the pregnant women who misused 
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prescription pain relievers, which will address this plan of action through guiding in the 
development of strategies and targeted actions.  
Comprehensive management of pregnant women especially concerning pain is a 
vital subject. CDC (2020) noted that MAT in combination with counseling, and 
behavioral therapies used to treat substance use disorders can lead to more favorable 
outcomes. One major concern with the misuse of prescription pain relievers by pregnant 
women is the effects it will have on the unborn child. NAS can be a consequence of using 
MAT among pregnant women hence clinicians should discuss the benefits that outweigh 
this. According to CDC (2020), providing families with plans of safe care is fundamental. 
Pregnant women should also be screened for other mental health conditions. 
Anxiety and depression have been listed to affect women who misuse prescription pain 
relievers especially opioids (CDC, 2020). Screening for depression, anxiety, and other 
mental health conditions should be done for all pregnant women especially those of the 
non-African-American race and this should be done to include providing access or 
referrals to appropriate psychosocial support as needed CDC, 2020).  
Conclusion 
The misuse of prescription pain relievers is a public health concern that needs 
interventions and Bonnie et al. (2019) explained that with the increased recognition of 
pain and its diagnosis, more physicians are prescribing pain relievers leading to an 
increase in its accessibility and consequently its misuse. CDC (2018) and NIDA (2020) 
listed hydrocodone as one of the most misused prescription pain relievers and this study 
found that it was the most misused prescription pain reliever among pregnant women. 
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Education level was not associated with the misuse of prescription pain relievers among 
the pregnant women while race was. Non-African-American pregnant women were more 
likely to misuse prescription pain relievers. Prevention and intervention programs 
addressing the misuse of prescription pain relievers are necessary especially targeting 
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1 Education .993 1.007 
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1 Pain reliever 1.000 1.000 
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